Mulligan Seamus 4
4 · Jazz Pharmaceuticals plc · Filed Mar 7, 2023
Insider Transaction Report
Form 4
Mulligan Seamus
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2023-03-04$59.13/sh+4,500$266,085→ 1,164,800 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2023-03-04−4,500→ 0 totalExercise: $59.13Exp: 2023-03-04→ Ordinary Shares (4,500 underlying)
Footnotes (1)
- [F1]The option was granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Option Plan and vested in 12 monthly installments over one year from the grant date, March 5, 2013.